Sysmex Europe
Menu

Sysmex Presents Academic report with a View to Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood

Presenting the Most Recent Data at the 13th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu; "Sysmex") will present one poster showing the most recent data on using blood as a method of diagnosing Alzheimer’s disease at the 13th Clinical Trials on Alzheimer's Disease (CTAD) conference, held virtually from November 4 to 7, 2020. Sysmex is conducting this development in collaboration with Eisai Co., Ltd. (HQ: Tokyo, Japan; CEO: Haruo Naito; "Eisai").


In February 2016, Sysmex and Eisai signed a non-exclusive comprehensive agreement aimed at the creation of new diagnostics in the field of dementia. By leveraging each other’s technologies and knowledge, we aim to discover next-generation diagnostic drugs that will enable early diagnosis, selection of the treatment options and the regular monitoring of the effects of treatment for dementia.

Sysmex and Eisai are pursuing joint development aimed at creating a simple method of diagnosing Alzheimer’s disease using blood. At CTAD, Sysmex will announce the most recent data produced by an automated protein assay system using its protein measurement platform, the HISCLTM fully automated immunoassay system.

  Subject

Presenter

(Affiliation)

Clinical trials: biomarkers including plasma

LP10

Plasma Aβ ratio measured on a fully automated immunoassay predicts amyloid positivity defined by amyloid PET centiloid

Poster presentation: November 4 (Wed.) to November 7 (Sat.)

Kazuto Yamashita

(Sysmex)

Sysmex is working to create new diagnostic technologies for the prevention and treatment of dementia. As a result, we aim to contribute to the advancement of healthcare and improve the quality of life for patients and their families.

 

Information contained in the press release is current as of the date of the announcement but may be subject to change without prior notice.
Back to overview

 

 

Copyright © Sysmex Europe GmbH. All rights reserved.
Customize your experience

We use cookies to enable you to optimally use our Website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

* May lead to restrictions in content and in the user experience
Detail about cookies
Essential cookies
These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.
Statistics cookies
By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.
Marketing cookies
are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.